β2-microglobulin (B2M), an essential molecular chaperone for HLA-I–mediated antigen presentation, is frequently lost in NSCLC, resulting in an immunosuppressive TME characterized by reduced tumor-infiltrating lymphocytes and ICI resistance (67, 70). Here, B2M is linked to non-small cell lung carcinoma.